Navigation Links
John D. Baxter, M.D. Joins Bionovo's Board of Directors
Date:4/17/2008

EMERYVILLE, Calif., April 17 /PRNewswire-FirstCall/ -- Bionovo Inc. (Nasdaq: BNVI) announced today the appointment of John D. Baxter, M.D., to the company's Board of Directors. Dr. Baxter has extensive experience in academic research as well as with pharmaceutical and biotech companies, and in particular in advancing endocrine drugs.

"We are very excited to have John on board as we are advancing our clinical trial programs," said Isaac Cohen, O.M.D., Bionovo's Chairman and CEO. He added, "John is a pioneer in endocrine research as well as one of the first to bridge the academic and industrial relationship, transforming his major discoveries in science into therapies. John's work in endocrinology and his experience with Wall Street make him a perfect fit with our platform at Bionovo in women's health".

Dr. Baxter says, "I'm very impressed by the potential for Bionovo's drugs and the knowledge of their mechanisms of action. There appear to be solid studies of the molecular toxicology of the drugs, as well as promising clinical results. I believe the pipeline of Bionovo will provide new therapies for women."

Dr. Baxter and his collaborators first cloned the growth hormone gene and achieved recombinant DNA synthesis of growth hormone in bacteria which led to the development of growth hormone as a product. His work provided critical advances in recombinant technologies for gene and protein expression as well as the understanding of human growth and development. His group also first cloned bovine growth hormone gene sequences and produced bovine growth hormone that subsequently was developed as a product, that has made a difference to the dairy industry, and promises to increase the ability for food production worldwide. '/>"/>

SOURCE Bionovo Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Richard Greco Joins Mediware Board
2. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
3. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
4. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
5. Nick Childs Joins Grey New York as Director of Content Development
6. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
7. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
8. NASN Joins Partnership to Fight Chronic Disease
9. AstraZeneca Joins Local Walking Movement
10. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
11. Fund Manager Joins Board of GSI Securitization Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)... - 180-Days of Marketing Exclusivity Beg...all/ -- Watson,Pharmaceuticals, Inc. (NYSE: WPI )...unced today that its subsidiary has commenced comm...Capsules USP product in the 40mg,strength from its...tion,with the launch, Watson has 180 days of marke...
(Date:7/25/2008)...CHAUMBURG, Ill., July 25 /PRNewswire/ -- Sagent Ph...armaceutical company, today announced that it,has ...I antiarrhythmic,indicated for the treatment and p...rillation and hemodynamically unstable ventricular...egular heart beat.,Sagent,s amiodarone HCl injecti...
(Date:7/25/2008)...ARLSBAD, Calif., July 25 /PRNewswire/ -- AutoGenom...stration statement on Form S-1 with the,Securities...initial public,offering of shares of its common st...fered, all of which are expected to be offered by,...fering, have not yet been,determined., J.P. Morga...
(Date:7/25/2008)... New program delivers immediat...ml [24-hour telephone access to language interpre...eking multilingual solutions. , ...-- LLE® http://www.lle-inc.com/index.html [...provider of interpretation, translation, and langu...
Breaking Medicine News(10 mins):Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3
...althy, naturally occurring substance with many hea...mate medical use? GHB -- gamma hydroxy butyric aci...s// of its career, has been blamed as an illegal k...housands of deaths and emergency room visits, whil...
...of obese children are already showing signs of ch...finding sustains doctors' fears that many of today...ey to the disabling disease before they hit their ...time that being obese, or even overweight, can gre...
...m may help to make people smarter by improving mem...ests, scientists found the ability to recall remem...d gum.// The scientists from the University of Nor...e working on two theories. One is that chewing ra...
... folic acid intake and decreasing alcohol help bea...n cancer. According to previous studies have shown...u have a sibling or parent with the disease, you c...wn on red meat and eat lots of fruit and vegetable...
Other Medicine News:
(Date:7/22/2008)...tes Feasibility and Efficacy of Treating Patients ..., SAN FRANCISCO, and YONGIN-SI, South Korea, July... CA and Ottawa, Ontario), and its South,Korean par... findings from,a Phase I clinical trial of its fir...the product was well-tolerated and resulted in cle...
(Date:7/22/2008)...lan Will Stress the Importance to Patients of Pass...l Pathway, RICHMOND, Va., July 22 /PRNewswire-Fir...er of follow-on biologics and biopharmaceuticals, ... Insmed, will present at a,Congressional briefing ...ant need for establishing an approval pathway for ...
(Date:7/22/2008)... Validated by Columbia University Medical Center B...croRNA Technology, The Test Differentiates Squam...(NSCLC), Classifying Squamous-Cell Carcinoma of th...pecificity of 90 Percent,This is the First CLIA Ap... as Biomarkers for Accurate Diagnosis of ...
(Date:7/22/2008)...s an Individual,s Genetic Risk Based on Clinical D... Educational Materials, WALTHAM, Mass., July 22 /.... (Amex: ILI ), today announced the launch of an ...e for the company,s Heart Health Genetic Test.,The...ensona(R) Heart Health,Genetic Test by Quixtar/Amw...
Breaking Medicine Technology:Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 2Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 3APC papers in global theme issue on poverty 4283 1Can the Web Transform the U S Healthcare System 3F 4281 1Can the Web Transform the U S Healthcare System 3F 4281 2Can the Web Transform the U S Healthcare System 3F 4281 3DoD and VA to Reduce Healthcare Supply Chain Costs 4279 1DoD and VA to Reduce Healthcare Supply Chain Costs 4279 2DoD and VA to Reduce Healthcare Supply Chain Costs 4279 3DoD and VA to Reduce Healthcare Supply Chain Costs 4279 4New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs 4277 1New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs 4277 2New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs 4277 3New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs 4277 4
...xas--(BUSINESS WIRE)--Jun 27, 2007 - Opexa,Therape...he,development and commercialization of cell thera...ternational Society for Stem Cell,Research Annual ...rom June 17-20 and at the 13th Annual Meeting of t...T) in Sydney, Australia from June,24-27. The two p...
...SS WIRE)--Jun 27, 2007 - Gentium S.p.A. (Nasdaq:,G...nd preclinical,data that support the safety, activ...Defibrotide in combination with anticancer,therapy... an update,from the Company,s ongoing Phase I/II c...psed multiple myeloma with Defibrotide in,combinat...
Other Medicine Technology:Opexa Advances Monocyte Derived Islet Technology to Proof of,Principle in stz-induced NOD/SCID Mice 2Opexa Advances Monocyte Derived Islet Technology to Proof of,Principle in stz-induced NOD/SCID Mice 3Gentium's Defibrotide Seen as Active in Multiple Myeloma 2Gentium's Defibrotide Seen as Active in Multiple Myeloma 3
...leep System is an easy-to-use, workflow-based syst...lts. Inspirex consists of the SleepWorks software...ugged and durable systems can be used for a comple...s - including full EEG recording - and have superi...
...ieval System is made up of three integral componen...ter and the Merci Balloon Guide Catheter. The syst... Once the location of the clot has been identified...er is inserted through a small incision in the fem...
... level of care you can provide to your patients, D...ng innovative products, standardization and reimbu...Davol® pulsed lavage systems deliver the perfo...otic tissue, bacteria, and foreign material. Each ...
The Simpulse Solo Pulsed Lavage System requires minimal set up and has a Wide range of tips available for every orthopaedic procedure. It uses a separate suction lumen to reduce clogging and n ergono
Medicine Products: